Your session is about to expire
← Back to Search
Device
Vagal Nerve Stimulation for Post-COVID Syndrome
N/A
Recruiting
Led By Ravindra Ganesh
Research Sponsored by Mayo Clinic
Eligibility Criteria Checklist
Specific guidelines that determine who can or cannot participate in a clinical trial Must have
Presence of headache
Clinical diagnosis of post COVID syndrome
Timeline
Screening 3 weeks
Treatment Varies
Follow Up baseline to 12 weeks
Awards & highlights
Study Summary
This trial will test if a device that sends electrical signals to the vagus nerve can help improve symptoms in people who have fatigue and headaches after contracting COVID-19.
Who is the study for?
This trial is for individuals who have been diagnosed with post COVID syndrome and are experiencing persistent fatigue, headaches, and post exertional malaise. Participants must be able to engage in all study activities. Those with metallic neck devices, active implants like pacemakers or hearing aids, pregnancy, prior adverse reactions to 14FDG, or using other electronic devices simultaneously are excluded.Check my eligibility
What is being tested?
The trial is testing the effectiveness of a vagal nerve stimulator on alleviating symptoms of fatigue and headache in patients suffering from post COVID syndrome. The goal is to see if this treatment can improve their condition.See study design
What are the potential side effects?
Potential side effects may include discomfort at the stimulation site, voice changes due to nerve activation, tingling sensations or muscle twitching near the neck area where the device operates.
Eligibility Criteria
Inclusion Criteria
You may be eligible if you check “Yes” for the criteria belowSelect...
I experience headaches.
Select...
I have been diagnosed with long COVID.
Timeline
Screening ~ 3 weeks3 visits
Treatment ~ Varies
Follow Up ~ baseline to 12 weeks
Screening ~ 3 weeks
Treatment ~ Varies
Follow Up ~baseline to 12 weeks
Treatment Details
Study Objectives
Outcome measures can provide a clearer picture of what you can expect from a treatment.Primary outcome measures
Change in Post-COVID Functional Status Score
Trial Design
2Treatment groups
Experimental Treatment
Active Control
Group I: VNS TreatmentExperimental Treatment1 Intervention
Subjects with post COVID syndrome with fatigue and headache will have vagal nerve stimulator applied to the neck for 2 minute intervals with two sets administered three times daily
Group II: Non-VNS TreatmentActive Control1 Intervention
Subjects with post COVID syndrome with fatigue and headache will receive current standard of care
Find a Location
Who is running the clinical trial?
Mayo ClinicLead Sponsor
3,205 Previous Clinical Trials
3,766,764 Total Patients Enrolled
Ravindra GaneshPrincipal InvestigatorMayo Clinic
Media Library
Eligibility Criteria:
This trial includes the following eligibility criteria:- I experience headaches.I have been diagnosed with long COVID.I can take part in all parts of the study.You have had a bad reaction to 14FDG before.I often feel very tired and worse after physical activity.You are not using another electronic device at the same time, like a TENS machine or a mobile phone.I often feel very tired and worse after physical activity.You have a metal device such as a stent or orthopedic hardware in your neck.
Research Study Groups:
This trial has the following groups:- Group 1: VNS Treatment
- Group 2: Non-VNS Treatment
Awards:
This trial has 1 awards, including:- No Placebo-Only Group - All patients enrolled in this study will receive some form of active treatment.
Timeline:
This trial has the following timeline:- Screening: It may take up to 3 Weeks to process to see if you qualify in this trial.
- Treatment: The duration you will receive the treatment varies.
- Follow Ups: You may be asked to continue sharing information regarding the trial for 6 Months after you stop receiving the treatment.
Frequently Asked Questions
These questions and answers are submitted by anonymous patients, and have not been verified by our internal team.
Is participation in this experiment still possible for those who meet the criteria?
"This clinical trial is not currently accepting new candidates; however, its listing on clinicialtrials.gov specifies that it was initially posted in October 1st 2022 and last updated four days later. There are still 1723 other trials seeking participants at this time."
Answered by AI
Who else is applying?
What state do they live in?
Minnesota
What site did they apply to?
Mayo Clinic in Rochester
What portion of applicants met pre-screening criteria?
Met criteria
Recent research and studies
Share this study with friends
Copy Link
Messenger